STOCK TITAN

Septerna to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Septerna (Nasdaq: SEPN) announced management will participate in two investor conferences in November 2025: a Guggenheim fireside chat on November 10, 2025 at 4:00 p.m. ET and a TD Cowen Immunology & Inflammation Summit fireside chat on November 12, 2025 at 4:00 p.m. ET.

Both presentations will be live webcast and available in the investors section at www.septerna.com. Replays will be archived for at least 30 days after each event.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

-2.67% News Effect

On the day this news was published, SEPN declined 2.67%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

SOUTH SAN FRANCISCO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today announced that management will participate in the following upcoming investor conferences in November:

Guggenheim 2nd Annual Healthcare Innovation Conference
Fireside chat on Monday, November 10, 2025, at 4:00 p.m. ET

TD Cowen Immunology & Inflammation Summit
Fireside chat on Wednesday, November 12, 2025, at 4:00 p.m. ET

Live webcasts of the presentations will be available in the investors section of the company’s website at www.septerna.com. Replays will be archived for at least 30 days following each event.

About Septerna
Septerna, Inc. is a clinical-stage biotechnology company with a world-class team of GPCR experts and drug developers advancing cutting-edge science to unlock the full potential of GPCR therapies for patients with significant unmet needs. The company’s proprietary Native Complex Platform™ is designed to enable new approaches to GPCR drug discovery and has led to the development of a diverse pipeline of novel oral small molecule drug candidates. Septerna is advancing programs in endocrinology, immunology and inflammation, metabolic diseases and additional therapeutic areas, both independently and with partners. For more information, please visit www.septerna.com.

Investor Contact:
Renee Leck, THRUST
renee@thrustsc.com

Media Contact:
Carly Scaduto, THRUST
carly@thrustsc.com 


FAQ

When will Septerna (SEPN) present at the Guggenheim Healthcare Innovation Conference?

Septerna will present a fireside chat on November 10, 2025 at 4:00 p.m. ET.

When is Septerna (SEPN) scheduled to speak at the TD Cowen Immunology & Inflammation Summit?

The company will hold a fireside chat on November 12, 2025 at 4:00 p.m. ET.

Where can investors watch Septerna (SEPN) webcasts for the November 2025 conferences?

Live webcasts and archived replays will be available in the Investors section at www.septerna.com.

How long will Septerna (SEPN) keep replays of the November 2025 presentations online?

Replays will be archived for at least 30 days after each event.

Will Septerna (SEPN) provide Q&A or investor materials during the November 2025 events?

The announcement notes fireside chats and webcasts; investors should check the www.septerna.com investors page for any posted materials or Q&A summaries.
Septerna, Inc.

NASDAQ:SEPN

SEPN Rankings

SEPN Latest News

SEPN Latest SEC Filings

SEPN Stock Data

1.28B
42.82M
2.94%
100.49%
6.91%
Biotechnology
Pharmaceutical Preparations
Link
United States
SOUTH SAN FRANCISCO